These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28383359)

  • 1. Amantadine for Antipsychotic-Related Weight Gain: Meta-Analysis of Randomized Placebo-Controlled Trials.
    Zheng W; Wang S; Ungvari GS; Ng CH; Yang XH; Gu YH; Li M; Xiang YQ; Xiang YT
    J Clin Psychopharmacol; 2017 Jun; 37(3):341-346. PubMed ID: 28383359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.
    Zheng W; Xiang YT; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Correll CU
    Acta Psychiatr Scand; 2016 Nov; 134(5):385-398. PubMed ID: 27585549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials.
    Zheng W; Li XB; Shi ZM; Yang XH; Cai DB; Ng CH; Ungvari GS; Liu WJ; Wu YJ; Wang YY; Ning YP; Xiang YT
    Pharmacopsychiatry; 2020 Jan; 53(1):5-13. PubMed ID: 31207653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
    Correll CU; Maayan L; Kane J; Hert MD; Cohen D
    J Clin Psychiatry; 2016 Jun; 77(6):e746-56. PubMed ID: 27337425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Cai DB; Yang XH; Ungvari GS; Ng CH; Müller N; Ning YP; Xiang YT
    J Psychiatr Res; 2017 Sep; 92():139-146. PubMed ID: 28445800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials.
    Xiang YQ; Zheng W; Wang SB; Yang XH; Cai DB; Ng CH; Ungvari GS; Kelly DL; Xu WY; Xiang YT
    Eur Neuropsychopharmacol; 2017 Jan; 27(1):8-18. PubMed ID: 27919523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Li XH; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang SB; Wang YY; Ning YP; Xiang YT
    Psychol Med; 2018 Jan; 48(1):72-81. PubMed ID: 28528597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Adjunctive Aripiprazole in Schizophrenia: Meta-Analysis of Randomized Controlled Trials.
    Zheng W; Zheng YJ; Li XB; Tang YL; Wang CY; Xiang YQ; de Leon J
    J Clin Psychopharmacol; 2016 Dec; 36(6):628-636. PubMed ID: 27755219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zhu XM; Zheng W; Li XH; Cai DB; Yang XH; Ungvari GS; Ng CH; Wang XP; Kulkarni J; Grigg J; Ning YP; Xiang YT
    Schizophr Res; 2018 Jul; 197():288-293. PubMed ID: 29395611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials.
    Gu XJ; Chen R; Sun CH; Zheng W; Yang XH; Wang SB; Ungvari GS; Ng CH; Golenkov A; Lok GKI; Li L; Chow IHI; Wang F; Xiang YT
    J Int Med Res; 2018 Jan; 46(1):22-32. PubMed ID: 28718688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Oya K; Kishi T; Iwata N
    Hum Psychopharmacol; 2014 Sep; 29(5):483-91. PubMed ID: 25087702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials.
    Zheng W; Cai DB; Zhang QE; He J; Zhong LY; Sim K; Ungvari GS; Ning YP; Xiang YT
    J Psychiatr Res; 2019 Jun; 113():27-33. PubMed ID: 30878789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Metformin and Lifestyle Intervention for Antipsychotic-Related Weight Gain: A Meta-Analysis of Randomized Controlled Trials.
    Zheng W; Zhang QE; Cai DB; Yang XH; Ungvari GS; Ng CH; Wu RR; Xiang YT
    Pharmacopsychiatry; 2019 Jan; 52(1):24-31. PubMed ID: 29486513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia.
    Solmi M; Veronese N; Thapa N; Facchini S; Stubbs B; Fornaro M; Carvalho AF; Correll CU
    CNS Spectr; 2017 Oct; 22(5):415-426. PubMed ID: 28181901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials.
    Zheng W; Cao XL; Ungvari GS; Xiang YQ; Guo T; Liu ZR; Wang YY; Forester BP; Seiner SJ; Xiang YT
    PLoS One; 2016; 11(6):e0156510. PubMed ID: 27285996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive azapirone for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Li XH; Cai DB; Yang XH; Ungvari GS; Ng CH; Ning YP; Xiang YT
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):149-158. PubMed ID: 29174529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Kishi T; Iwata N
    CNS Drugs; 2013 Sep; 27(9):731-41. PubMed ID: 23812802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Iwata N
    J Psychiatr Res; 2013 Sep; 47(9):1143-9. PubMed ID: 23692933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.